{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:06:19Z","timestamp":1768370779394,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02173-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:34:46Z","timestamp":1767951286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational pharmacovigilance of Lifitegrast in dry eye disease using machine learning and network toxicology"],"prefix":"10.1038","volume":"9","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[]},{"given":"Shixiang","family":"Jing","sequence":"additional","affiliation":[]},{"given":"Xuhua","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Xinyue","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Chunyu","family":"Liang","sequence":"additional","affiliation":[]},{"given":"Leite","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Pengyi","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Kunpeng","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[]},{"given":"Haiyan","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xuemin","family":"Jin","sequence":"additional","affiliation":[]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2173_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P. et al. TFOS DEWS II definition and classification report. Ocul. Surf. 15, 276\u201383 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton, F. et al. TFOS DEWS II epidemiology report. Ocul. Surf. 15, 334\u201365 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 15, 438\u2013510 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","volume":"14","author":"VL Perez","year":"2016","unstructured":"Perez, V. L. et al. Lifitegrast, a novel integrin antagonist for treatment of dry eye disease. Ocul. Surf. 14, 207\u201315 (2016).","journal-title":"Ocul. Surf."},{"key":"2173_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/jop.2016.0105","volume":"33","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder, S. C., Stern, M., Zhang, S. & Shojaei, A. LFA-1\/ICAM-1 interaction as a therapeutic target in dry eye disease. J. Ocul. Pharm. Ther. 33, 5\u201312 (2017).","journal-title":"J. Ocul. Pharm. Ther."},{"key":"2173_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","volume":"121","author":"JD Sheppard","year":"2014","unstructured":"Sheppard, J. D. et al. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study. Ophthalmology 121, 475\u201383 (2014).","journal-title":"Ophthalmology"},{"key":"2173_CR7","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","volume":"122","author":"J Tauber","year":"2015","unstructured":"Tauber, J. et al. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology 122, 2423\u201331 (2015).","journal-title":"Ophthalmology"},{"key":"2173_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","volume":"124","author":"EJ Holland","year":"2017","unstructured":"Holland, E. J. et al. Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3). Ophthalmology 124, 53\u201360 (2017).","journal-title":"Ophthalmology"},{"key":"2173_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.drudis.2008.12.012","volume":"14","author":"M Hauben","year":"2009","unstructured":"Hauben, M. & Bate, A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov. Today 14, 343\u201357 (2009).","journal-title":"Drug Discov. Today"},{"key":"2173_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate, A. & Evans, S. J. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol. Drug Saf. 18, 427\u201336 (2009).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2173_CR11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/clpt.2012.50","volume":"91","author":"R Harpaz","year":"2012","unstructured":"Harpaz, R. et al. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin. Pharm. Ther. 91, 1010\u201321 (2012).","journal-title":"Clin. Pharm. Ther."},{"key":"2173_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Nor\u00e9n","year":"2013","unstructured":"Nor\u00e9n, G. N., Hopstadius, J. & Bate, A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat. Methods Med. Res. 22, 57\u201369 (2013).","journal-title":"Stat. Methods Med. Res."},{"key":"2173_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jbi.2015.02.004","volume":"54","author":"A Sarker","year":"2015","unstructured":"Sarker, A. et al. Utilizing social media data for pharmacovigilance: a review. J. Biomed. Inform. 54, 202\u201312 (2015).","journal-title":"J. Biomed. Inform."},{"key":"2173_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jbi.2015.03.010","volume":"55","author":"S Karimi","year":"2015","unstructured":"Karimi, S., Metke-Jimenez, A., Kemp, M. & Wang, C. Cadec: a corpus of adverse drug event annotations. J. Biomed. Inform. 55, 73\u201381 (2015).","journal-title":"J. Biomed. Inform."},{"key":"2173_CR15","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1136\/amiajnl-2011-000699","volume":"19","author":"M Liu","year":"2012","unstructured":"Liu, M. et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J. Am. Med. Inf. Assoc. 19, e28\u201335 (2012).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"2173_CR16","doi-asserted-by":"publisher","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti, N. P., Ye, P. P., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra31 (2012).","journal-title":"Sci. Transl. Med."},{"key":"2173_CR17","doi-asserted-by":"publisher","first-page":"114ra127","DOI":"10.1126\/scitranslmed.3002774","volume":"3","author":"A Cami","year":"2011","unstructured":"Cami, A., Arnold, A., Manzi, S. & Reis, B. Predicting adverse drug events using pharmacological network models. Sci. Transl. Med. 3, 114ra127 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2173_CR18","unstructured":"Devlin, J., Chang, M. W., Lee, K. & Toutanova, K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. In Proc. the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (NAACL-HLT 2019), 4171\u20134186 (Association for Computational Linguistics, 2019)."},{"key":"2173_CR19","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. Xgboost: a scalable tree boosting system. In Proc. 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 (ACM, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"2173_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5212","volume":"5","author":"X Zhou","year":"2014","unstructured":"Zhou, X., Menche, J., Barab\u00e1si, A. L. & Sharma, A. Human symptoms-disease network. Nat. Commun. 5, 4212 (2014).","journal-title":"Nat. Commun."},{"key":"2173_CR21","doi-asserted-by":"crossref","first-page":"e84912","DOI":"10.1371\/journal.pone.0084912","volume":"9","author":"C Liu","year":"2014","unstructured":"Liu, C. et al. Mining drug-drug interactions from literature using a cascaded framework. PLoS ONE 9, e84912 (2014).","journal-title":"PLoS ONE"},{"key":"2173_CR22","first-page":"615","volume":"57","author":"A Rogers","year":"2020","unstructured":"Rogers, A., Kovaleva, O. & Rumshisky, A. A primer on neural network models for natural language processing. J. Artif. Intell. Res. 57, 615\u201387 (2020).","journal-title":"J. Artif. Intell. Res."},{"key":"2173_CR23","first-page":"993","volume":"3","author":"DM Blei","year":"2003","unstructured":"Blei, D. M., Ng, A. Y. & Jordan, M. I. Latent Dirichlet allocation. J. Mach. Learn. Res. 3, 993\u20131022 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"2173_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"2173_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273\u201397 (1995).","journal-title":"Mach. Learn."},{"key":"2173_CR26","unstructured":"Huynh, T., He, Y., Willis, A. & R\u00fcger, S. Adverse drug reaction classification with deep neural networks. In Proc. COLING 2016 877\u2013887 (Association for Computational Linguistics, 2016)."},{"key":"2173_CR27","unstructured":"Zhao, S. et al. Mining adverse drug events from structured product labels using deep learning. IEEE International Conference on Bioinformatics and Biomedicine 976\u2013981 (IEEE, 2017)."},{"key":"2173_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/jamia\/ocu041","volume":"22","author":"A Nikfarjam","year":"2015","unstructured":"Nikfarjam, A. et al. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features. J. Am. Med. Inf. Assoc. 22, 671\u201381 (2015).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"2173_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00001888-199908000-00012","volume":"74","author":"C Friedman","year":"1999","unstructured":"Friedman, C. & Hripcsak, G. Natural language processing and its future in medicine. Acad. Med. 74, 890\u20135 (1999).","journal-title":"Acad. Med."},{"key":"2173_CR30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.ajo.2011.11.003","volume":"153","author":"CP Semba","year":"2012","unstructured":"Semba, C. P. et al. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye. Am. J. Ophthalmol. 153, 1050\u201360 (2012).","journal-title":"Am. J. Ophthalmol."},{"key":"2173_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1120672118791936","volume":"29","author":"KK Nichols","year":"2019","unstructured":"Nichols, K. K. et al. Safety and tolerability of lifitegrast ophthalmic solution 5.0%: pooled analysis of five randomized controlled trials in dry eye disease. Eur. J. Ophthalmol. 29, 394\u2013401 (2019).","journal-title":"Eur. J. Ophthalmol."},{"key":"2173_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18433\/jpps29895","volume":"22","author":"CC Chan","year":"2019","unstructured":"Chan, C. C. & Prokopich, C. L. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: overview of clinical trial program. J. Pharm. Pharm. Sci. 22, 49\u201356 (2019).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"2173_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/14656566.2017.1372748","volume":"18","author":"ED Donnenfeld","year":"2017","unstructured":"Donnenfeld, E. D., Perry, H. D., Nattis, A. S. & Rosenberg, E. D. Lifitegrast for the treatment of dry eye disease in adults. Expert Opin. Pharmacother. 18, 1517\u201324 (2017).","journal-title":"Expert Opin. Pharmacother."},{"key":"2173_CR34","doi-asserted-by":"publisher","first-page":"P286","DOI":"10.1016\/j.ophtha.2018.10.023","volume":"126","author":"EK Akpek","year":"2019","unstructured":"Akpek, E. K. et al. Dry eye syndrome preferred practice pattern\u00ae. Ophthalmology 126, P286\u2013P334 (2019).","journal-title":"Ophthalmology"},{"key":"2173_CR35","first-page":"337","volume":"18","author":"MO Riedl","year":"2012","unstructured":"Riedl, M. O. & Biemann, C. Text segmentation with topic models. J. Nat. Lang. Eng. 18, 337\u201359 (2012).","journal-title":"J. Nat. Lang. Eng."},{"key":"2173_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","volume":"136","author":"DA Schaumberg","year":"2003","unstructured":"Schaumberg, D. A., Sullivan, D. A., Buring, J. E. & Dana, M. R. Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 136, 318\u201326 (2003).","journal-title":"Am. J. Ophthalmol."},{"key":"2173_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovi\u0107","year":"2007","unstructured":"Miljanovi\u0107, B., Dana, R., Sullivan, D. A. & Schaumberg, D. A. Impact of dry eye syndrome on vision-related quality of life. Am. J. Ophthalmol. 143, 409\u201315 (2007).","journal-title":"Am. J. Ophthalmol."},{"key":"2173_CR38","first-page":"296","volume":"58","author":"CW McMonnies","year":"1987","unstructured":"McMonnies, C. W. & Ho, A. Patient history in screening for dry eye conditions. J. Am. Optom. Assoc. 58, 296\u2013301 (1987).","journal-title":"J. Am. Optom. Assoc."},{"key":"2173_CR39","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes. CLAO J. 21, 221\u201332 (1995).","journal-title":"CLAO J."},{"key":"2173_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson, W., Chauhan, S. K. & Dana, R. Dry eye disease: an immune-mediated ocular surface disorder. Arch. Ophthalmol. 130, 90\u2013100 (2012).","journal-title":"Arch. Ophthalmol."},{"key":"2173_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/jop.2019.0060","volume":"36","author":"LM Periman","year":"2020","unstructured":"Periman, L. M. et al. The immunological basis of dry eye disease and current topical treatment options. J. Ocul. Pharm. Ther. 36, 137\u201346 (2020).","journal-title":"J. Ocul. Pharm. Ther."},{"key":"2173_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/OPTH.S152841","volume":"12","author":"KK Nichols","year":"2018","unstructured":"Nichols, K. K. et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a phase III randomized controlled trial. Clin. Ophthalmol. 12, 263\u201370 (2018).","journal-title":"Clin. Ophthalmol."},{"key":"2173_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes, J. A. P. et al. TFOS DEWS II iatrogenic report. Ocul. Surf. 15, 511\u201338 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones, L. et al. TFOS DEWS II management and therapy report. Ocul. Surf. 15, 575\u2013628 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn, J. S. et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 15, 539\u201374 (2017).","journal-title":"Ocul. Surf."},{"key":"2173_CR46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman, R. M. et al. Reliability and validity of the ocular surface disease index. Arch. Ophthalmol. 118, 615\u201321 (2000).","journal-title":"Arch. Ophthalmol."},{"key":"2173_CR47","first-page":"CD010051","volume":"9","author":"CS de Paiva","year":"2019","unstructured":"de Paiva, C. S., Pflugfelder, S. C., Ng, S. M. & Akpek, E. K. Topical cyclosporine A therapy for dry eye syndrome. Cochrane Database Syst. Rev. 9, CD010051 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2173_CR48","unstructured":"Leaman, R. et al. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In Proc. 2010 Workshop on Biomedical Natural Language Processing 117\u2013125 (Association for Computational Linguistics, 2010)."},{"key":"2173_CR49","unstructured":"Mikolov, T., Chen, K., Corrado, G. & Dean, J. Efficient estimation of word representations in vector space. In Proc. International Conference on Learning Representations (ICLR) Workshop (International Conference on Learning Representations, 2013)."},{"key":"2173_CR50","doi-asserted-by":"crossref","unstructured":"Pennington, J., Socher, R. & Manning, C. D. Glove: Global vectors for word representation. In Proc. 2014 Conference on Empirical Methods in Natural Language Processing (EMNLP), 1532\u20131543 (Association for Computational Linguistics, 2014).","DOI":"10.3115\/v1\/D14-1162"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02173-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:14:36Z","timestamp":1768342476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02173-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02173-1","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}